Clinical Trial Detail

NCT ID NCT03032406
Title CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

breast cancer

Therapies

Everolimus + Hydroxychloroquine

Everolimus

Hydroxychloroquine

Age Groups: senior adult

Additional content available in CKB BOOST